Page 176 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

152 Ezgi Deniz Batu and Seza Ozen

[26] Saulsbury, F. T. Henoch-Schönlein purpura. Curr. Opin. Rheumatol. 2001; 13:35-40.
[27] American Academy of Pediatrics Council on Child and Adolescent Health: Age limits

of pediatrics. Pediatrics 1988; 81:736.
[28] Kawasaki, Y. The pathogenesis and treatment of pediatric Henoch-Schönlein purpura

nephritis. Clin. Exp. Nephrol. 2011; 15:648-657.
[29] Shulman, S. T., Rowley, A. H. Advances in Kawasaki disease. Eur. J. Pediatr. 2004;

63:285-291.
[30] Dillon, M. J., Eleftheriou, D., Brogan, P. A. Medium-size-vessel vasculitis. Pediatr.

Nephrol. 2010; 25:1641-1652.
[31] De Rosa, G., Pardeo, M., Rigante, D. Current recommendations for the pharmacologic

therapy in Kawasaki syndrome and management of its cardiovascular complications.
Eur. Rev. Med. Pharmacol. Sci. 2007; 11:301-308.
[32] Japan Kawasaki Disease Research Committee. Diagnostic guidelines for Kawasaki
disease. 5th Ed. Tokyo, 2002.
[33] Newburger, J. W., Takahashi, M., Gerber, M. A., et al. Diagnosis, treatment and long-
term management of Kawasaki disease: a statement for health professionals from the
Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on
Cardiovascular Disease in the Young. Pediatrics 2004; 114:1708-1733.
[34] Watts, R. A., Scott, D. G. I. Epidemiology of vasculitis. In: Ball, G. V., Bridges, S. L.,
eds. Vasculitis, 2nd Ed. Oxford University Press, Oxford, 2008:7-21.
[35] Brogan, P. A., Davies, R., Gordon, I., et al. Renal angiography in children with
polyarteritis nodosa. Pediatr. Nephrol. 2002; 17:277-283.
[36] Ozen, S., Besbas, N., Saatci, U., et al. A. Diagnostic criteria for polyarteritis nodosa in
childhood. J. Pediatr. 1992; 120:206-209.
[37] Bastian, H. M. Cutaneous polyarteritis nodosa. In: Ball, G. V., Bridges, S. L., eds.
Vasculitis, 2nd Ed. Oxford University Press, Oxford, 2008; 365-372.
[38] Jennette, J. C., Falk, R. J., Andrassy, K., et al. Nomenclature of systemic vasculitides.
Proposal of an international consensus conference. Arthritis Rheum. 1994; 37:187-192.
[39] Gardner-Medwin, J. M., Dolezalova, P., Cummins, C., et al. Incidence of Henoch-
Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different
ethnic origins. Lancet 2002; 360:1197-1202.
[40] Vanoni, F., Bettinelli, A., Keller, F., et al. Vasculitides associated with IgG
antineutrophil cytoplasmic autoantibodies in childhood. Pediatr. Nephrol. 2010; 25:
205-212.
[41] Rottem, M., Fauci, A. S., Hallahan, C. W., et al. Wegener granulomatosis in children
and adolescents: clinical presentation and outcome. J. Pediatr. 1993; 122:26-31.
[42] Belostotsky, V. M., Shah, V., Dillon, M. J. Clinical features in 17 paediatric patients
with Wegener granulomatosis. Pediatr. Nephrol. 2002; 17:754-761.
[43] Watts, R., Al-Taiar, A., Mooney, J., et al. The epidemiology of Takayasu arteritis in the
UK. Rheumatology 2009; 48:1008-1011.
[44] Lane, S. E., Watts, R., Scott, D. G. Epidemiology of systemic vasculitis. Curr.
Rheumatol. Rep. 2005; 7:270-275.
[45] Ozen, S. The spectrum of vasculitis in children. Best Pract. Res. Clin. Rheumatol. 2002;
16:411-425.
[46] Vanoli, M., Daina, E., Salvarani, C., et al. Takayasu?s arteritis: A study of 104 Italian
patients. Arthritis Rheum. 2005; 53:100-107.

Complimentary Contributor Copy